HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Firms Share NDI Notification Tips And Experts Reveal Common Pitfalls

This article was originally published in The Tan Sheet

Executive Summary

Early and frequent communication with FDA is key to earning an elusive FDA acceptance of a new dietary ingredient notification on the first try, an agriculture-tech firm executive says

You may also be interested in...

FDA "Not Happy" Without NDI Guidance, Works To Improve Acceptance Rates

FDA is working to raise the acceptance rate for new dietary ingredient notifications from the current level of roughly 25 percent even as much-needed industry guidance is delayed, a Center for Food Safety and Applied Nutrition executive says

Ovos Plots Vivimind Cognitive Supplement Launch, Awaits FDA Reply

Ovos Natural Health plans a 2010 U.S. launch of its Vivimind cognitive health supplement, contingent upon FDA's go-ahead

Economic Pressures Push More Consumers To Buy Supplements - CRN Survey

The slumping economy is not slowing consumers' use of dietary supplements even as questions grow about the safety of some products, a Council for Responsible Nutrition survey shows

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts